-
1
-
-
0242582180
-
Islet regeneration during the reversal of autoimmune diabetes in NOD mice
-
Kodama S, Kuhtreiber W, Fujimura S, Dale EA, Faustman DL. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003;302:1223-7.
-
(2003)
Science
, vol.302
, pp. 1223-1227
-
-
Kodama, S.1
Kuhtreiber, W.2
Fujimura, S.3
Dale, E.A.4
Faustman, D.L.5
-
2
-
-
11444264876
-
Routes to regenerating islet cells: Stem cells and other biological therapies for type 1 diabetes
-
Kodama S, Faustman DL. Routes to regenerating islet cells: stem cells and other biological therapies for type 1 diabetes. Pediatr Diabetes 2004;5:Suppl 2:38-44.
-
(2004)
Pediatr Diabetes
, vol.5
, Issue.2 SUPPL.
, pp. 38-44
-
-
Kodama, S.1
Faustman, D.L.2
-
3
-
-
33645226291
-
Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration
-
Chong AS, Shen J, Tao J, et al. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration. Science 2006;311:1774-5.
-
(2006)
Science
, vol.311
, pp. 1774-1775
-
-
Chong, A.S.1
Shen, J.2
Tao, J.3
-
4
-
-
33645221626
-
Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution
-
Nishio J, Gaglia JL, Turvey SE, Campbell C, Benoist C, Mathis D. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science 2006;311:1775-8.
-
(2006)
Science
, vol.311
, pp. 1775-1778
-
-
Nishio, J.1
Gaglia, J.L.2
Turvey, S.E.3
Campbell, C.4
Benoist, C.5
Mathis, D.6
-
5
-
-
33645223082
-
Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells
-
Suri A, Calderon B, Esparza TJ, Frederick K, Bittner P, Unanue ER. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Science 2006;311:1778-80.
-
(2006)
Science
, vol.311
, pp. 1778-1780
-
-
Suri, A.1
Calderon, B.2
Esparza, T.J.3
Frederick, K.4
Bittner, P.5
Unanue, E.R.6
-
6
-
-
0025293535
-
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy
-
Sadelain MW, Qin HY, Lauzon J, Singh B. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 1990;39:583-9.
-
(1990)
Diabetes
, vol.39
, pp. 583-589
-
-
Sadelain, M.W.1
Qin, H.Y.2
Lauzon, J.3
Singh, B.4
-
7
-
-
0026502893
-
Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy
-
Wang T, Singh B, Warnock GL, Rajotte RV. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 1992;41:114-7.
-
(1992)
Diabetes
, vol.41
, pp. 114-117
-
-
Wang, T.1
Singh, B.2
Warnock, G.L.3
Rajotte, R.V.4
-
9
-
-
0037198420
-
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
-
Herold KC, Hagopian W, Auger JA, et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002;346:1692-8.
-
(2002)
N Engl J Med
, vol.346
, pp. 1692-1698
-
-
Herold, K.C.1
Hagopian, W.2
Auger, J.A.3
-
10
-
-
9644268967
-
PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance
-
Kulkarni RN, Jhala US, Winnay JN, Krajewski S, Montminy M, Kahn CR. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest 2004;114:828-36.
-
(2004)
J Clin Invest
, vol.114
, pp. 828-836
-
-
Kulkarni, R.N.1
Jhala, U.S.2
Winnay, J.N.3
Krajewski, S.4
Montminy, M.5
Kahn, C.R.6
|